Wright Medical launches long-term study for Infinity total ankle

Wright Medical (NSDQ:WMGI) said today that it launched a long-term study of the Infinity total ankle replacement device it introduced three years ago. The 10-year follow-up study of 200 patients aims to evaluate survivorship and to characterize improvements in patient-reported outcomes, Memphis-based Wright said. At its June 2014 debut, the company touted Infinity as a solution for both primary ankle arthroplasties and secondary or revision surgeries. The device is designed to be compatible with Wright’s Inbone II talar components and the Prophecy pre-operative alignment system. “With the growing popularity and increasing demand for alternatives to ankle fusion, there is a real need for quality, forward-looking studies that document the results of total ankle replacement surgery to further validate our clinical decision making,” primary investigator Dr. Andrew Murphy, of the Campbell Clinic in Memphis, said in prepared remarks. “Wright Medical is leading the way in this progress, and we expect to glean valuable data from this study of the Infinity total ankle system.” Wright also said the 500-patient post-market study in the U.K. it launched last year, also designed to evaluate 10-year survivorship and patient-reported outcomes, enrolled 100 patients as of the third quarter. “It is increasingly important for industry and clinicians to work together to provide patients, colleagues and healthcare providers with robust clinical evidence to suppo...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Orthopedics wrightmedical Source Type: news